Terms: = Brain cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
19 results:
1. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract] [Full Text] [Related]
2. An inhibitor of brd4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16.
Ma L; Li G; Yang T; Zhang L; Wang X; Xu X; Ni H
Cancer Chemother Pharmacol; 2022 Dec; 90(6):431-444. PubMed ID: 36224471
[TBL] [Abstract] [Full Text] [Related]
3. Primary intrapulmonary malignant peripheral nerve sheath tumor: A rare case.
Maane LA; Bouzidi AA; Damou M; Ismaili N
Cancer Treat Res Commun; 2020; 25():100243. PubMed ID: 33260029
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip.
Li Z; Li D; Guo Y; Wang Y; Su W
Biotechnol Lett; 2021 Feb; 43(2):383-392. PubMed ID: 33145669
[TBL] [Abstract] [Full Text] [Related]
5. Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon cancer.
Wu Y; Wan X; Jia G; Xu Z; Tao Y; Song Z; Du T
DNA Cell Biol; 2020 Nov; 39(11):1961-1969. PubMed ID: 33085517
[TBL] [Abstract] [Full Text] [Related]
6. Combination of metformin and cold atmospheric plasma induces glioma cell death to associate with c-Fos.
Yang F; Zhou Y; Yu H; Yang J; Zhu C; Ahmad N; Meng X; Zhao R; Zhuang J; Sun M
Neoplasma; 2021 Jan; 68(1):126-134. PubMed ID: 32880467
[TBL] [Abstract] [Full Text] [Related]
7. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract] [Full Text] [Related]
8. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
[TBL] [Abstract] [Full Text] [Related]
9. Fatty Acid-binding Protein 4 Expression in Tumor Cells as a Potential Marker for Anaplastic Meningiomas.
Lee V; Smith TW; Arikan MÇ; Zhang L; Çataltepe O; Çataltepe S
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):e10-e16. PubMed ID: 32324631
[TBL] [Abstract] [Full Text] [Related]
10. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.
Song H; Bhakat R; Kling MJ; Coulter DW; Chaturvedi NK; Ray S; Joshi SS
Biochem Biophys Res Commun; 2019 Dec; 520(2):250-256. PubMed ID: 31594641
[TBL] [Abstract] [Full Text] [Related]
11. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme.
Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH
World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer.
Li W; Dou Z; We S; Zhu Z; Pan D; Jia Z; Liu H; Wang X; Yu G
Biomed Pharmacother; 2018 Jun; 102():1105-1110. PubMed ID: 29710528
[TBL] [Abstract] [Full Text] [Related]
13. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
Goey KKH; Elias SG; van Tinteren H; Laclé MM; Willems SM; Offerhaus GJA; de Leng WWJ; Strengman E; Ten Tije AJ; Creemers GM; van der Velden A; de Jongh FE; Erdkamp FLG; Tanis BC; Punt CJA; Koopman M
Ann Oncol; 2017 Sep; 28(9):2128-2134. PubMed ID: 28911067
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of brd4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.
Venkataraman S; Alimova I; Balakrishnan I; Harris P; Birks DK; Griesinger A; Amani V; Cristiano B; Remke M; Taylor MD; Handler M; Foreman NK; Vibhakar R
Oncotarget; 2014 May; 5(9):2355-71. PubMed ID: 24796395
[TBL] [Abstract] [Full Text] [Related]
15. BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
Henssen A; Thor T; Odersky A; Heukamp L; El-Hindy N; Beckers A; Speleman F; Althoff K; Schäfers S; Schramm A; Sure U; Fleischhack G; Eggert A; Schulte JH
Oncotarget; 2013 Nov; 4(11):2080-95. PubMed ID: 24231268
[TBL] [Abstract] [Full Text] [Related]
16. Restoration of sensitivity in chemo-resistant glioma cells by cold atmospheric plasma.
Köritzer J; Boxhammer V; Schäfer A; Shimizu T; Klämpfl TG; Li YF; Welz C; Schwenk-Zieger S; Morfill GE; Zimmermann JL; Schlegel J
PLoS One; 2013; 8(5):e64498. PubMed ID: 23704990
[TBL] [Abstract] [Full Text] [Related]
17. Meningeal osteochondroma simulating meningioma with metaplastic change: a rare golf-ball-like lesion of non-meningothelial mesenchymal origin.
Majumdar K; Mandal S; Thakkar R; Saran RK; Srivastava AK
Brain Tumor Pathol; 2014 Jan; 31(1):62-7. PubMed ID: 23456087
[TBL] [Abstract] [Full Text] [Related]
18. Intracranial meningiomas in children: ten-year experience.
Maranhão-Filho P; Campos JC; Lima MA
Pediatr Neurol; 2008 Dec; 39(6):415-7. PubMed ID: 19027587
[TBL] [Abstract] [Full Text] [Related]
19. Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?
Kepes JJ
J Neuropathol Exp Neurol; 1986 Mar; 45(2):95-107. PubMed ID: 3005518
[TBL] [Abstract] [Full Text] [Related]
